Tci Wealth Advisors, Inc. Global Blood Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$22.3 - $37.39 $1,650 - $2,766	74 Added 36.27%	278 $9,000
Q1 2022 Apr 29, 2022	BUY	$25.68 - $35.59 $5,238 - $7,260	204 New	204 $7,000
Q4 2021 Jan 24, 2022	SELL	$24.9 - $40.26 $2,988 - $4,831	-120 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$25.48 - $37.34 $3,057 - $4,480	120 New	120 $3,000
Q4 2020 Jan 21, 2021	SELL	$37.65 - $63.77 $3,765 - $6,377	-100 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$45.7 - $81.86 $4,570 - $8,186	100 New	100 $8,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.